Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits. (Q54140064)

25 May 2018

title

Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits. (English)

1 reference

25 May 2018

1 reference

1 reference

aortic atherosclerosis

1 reference

Oshima R

1

1 reference

25 May 2018

Ikeda T

2

1 reference

25 May 2018

Watanabe K

3

1 reference

25 May 2018

Itakura H

4

1 reference

25 May 2018

Sugiyama N

5

1 reference

25 May 2018

publication date

1 March 1998

1 reference

25 May 2018

published in

Atherosclerosis

1 reference

25 May 2018

volume

137

1 reference

25 May 2018

issue

1

1 reference

25 May 2018

page(s)

13-22

1 reference

25 May 2018

Effects of probucol on xanthomata regression in familial hypercholesterolemia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Antiatherosclerotic effect of probucol in WHHL rabbits: are there plasma parameters to evaluate this effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit — long-term antiatherogenic effect and effects on established plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Comparison of gas chromatography and high-performance liquid chromatography for the analysis of probucol in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Isolation, characterization, and assay of plasma lipid transfer proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Continuous monitoring of in vitro oxidation of human low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Antioxidant activities of probucol against lipid peroxidations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Role of oxidized low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900243-8

10.1016/S0021-9150(97)00243-8

7 January 2021

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018